Free Trial

Vestcor Inc Has $721,000 Stock Position in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background
Remove Ads

Vestcor Inc trimmed its position in Maximus, Inc. (NYSE:MMS - Free Report) by 43.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,654 shares of the health services provider's stock after selling 7,543 shares during the quarter. Vestcor Inc's holdings in Maximus were worth $721,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. increased its holdings in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after buying an additional 158 shares in the last quarter. Eastern Bank acquired a new position in shares of Maximus during the fourth quarter worth $29,000. V Square Quantitative Management LLC increased its holdings in shares of Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after buying an additional 180 shares in the last quarter. R Squared Ltd acquired a new position in shares of Maximus during the fourth quarter worth $54,000. Finally, IFP Advisors Inc increased its holdings in shares of Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after buying an additional 302 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Insider Buying and Selling at Maximus

In other news, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.60% of the company's stock.

Remove Ads

Analysts Set New Price Targets

MMS has been the topic of several analyst reports. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

Read Our Latest Stock Report on Maximus

Maximus Trading Up 0.5 %

MMS traded up $0.32 during trading on Tuesday, reaching $68.34. 159,747 shares of the stock traded hands, compared to its average volume of 480,304. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $3.87 billion, a PE ratio of 14.68 and a beta of 0.71. The stock's 50-day moving average is $71.83 and its 200 day moving average is $79.13. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.76%. Maximus's dividend payout ratio (DPR) is currently 25.81%.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

7 Flying Car Stocks to Buy Before the Sector Really Takes Off
Institutions Are Dumping These 3 Stocks—Should You?
Will Tesla’s Robot Future Save Its Falling Stock?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads